ONMD

+ Watchlist + Portfolio

OneMedNet Corp

Regulated industry Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $5.50
52-Week Range: $4.90 – $42.20
Market Cap: $31.40M
P/E (TTM): —
EPS (TTM): -1.60
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: —
PEG Ratio: —
Return on Equity: —
Return on Assets: -342.10%
Gross Margin: -83.30%
Operating Margin: -774.32%
Profit Margin: 0.00%
Current Ratio: 0.28
Debt/Equity: —
Total Debt: $701.00K
Free Cash Flow: $-4.22M
Revenue Growth: 88.40%
Earnings Growth: —
Enterprise Value: $32.30M

ONMD Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$1.15M	$1.02M	$643.00K	$1.36M
Cost of Revenue	$1.51M	$1.15M	$924.00K	$1.86M
Gross Profit	-$360.00K	-$129.00K	-$281.00K	-$503.00K
Research & Development	$1.59M	$2.06M	$1.47M	$1.51M
Selling, General & Admin	$13.84M	$4.66M	$7.86M	$7.65M
Operating Expenses	$15.43M	$6.72M	$9.32M	$9.16M
Operating Income	-$15.79M	-$6.85M	-$9.61M	-$9.67M
EBITDA	-$30.41M	-$33.72M	-$9.92M	-$2.67M
Pretax Income	-$30.43M	-$33.76M	-$10.13M	-$2.80M
Income Tax	$17.00K	$18.00K	$2.00K	$1.00K
Net Income	-$30.45M	-$33.78M	-$10.13M	-$2.80M
Diluted EPS	-7.55	-4.65	-0.36	-0.06
Diluted Shares	4.03M	7.27M	28.08M	44.55M

ONMD Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$271.00K	$47.00K	$172.00K	$585.00K
Receivables	$19.00K	$152.00K	$213.00K	$495.00K
Current Assets	$391.00K	$365.00K	$3.62M	$2.10M
Total Assets	$1.29M	$464.00K	$3.73M	$2.15M
Current Liabilities	$26.10M	$13.84M	$19.23M	$4.83M
Long-Term Debt	$1.50M	$465.00K	—	$220.00K
Total Debt	$26.24M	$5.09M	$8.76M	$570.00K
Total Liabilities	$27.65M	$13.91M	$19.68M	$5.12M
Retained Earnings	-$57.66M	-$91.44M	-$101.57M	-$104.37M
Shareholders' Equity	-$26.36M	-$13.44M	-$15.95M	-$2.96M
Working Capital	-$25.71M	-$13.47M	-$15.61M	-$2.73M
Net Debt	$25.97M	$5.05M	$8.59M	—

ONMD Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$4.70M	-$4.79M	-$6.95M	-$7.50M
Capital Expenditure	-$58.00K	-$44.00K	-$51.00K	-$13.00K
Free Cash Flow	-$4.76M	-$4.83M	-$7.00M	-$7.52M
Depreciation & Amortisation	$25.00K	$28.00K	$57.00K	$65.00K
Stock-Based Compensation	$1.86M	$1.48M	$628.00K	$2.03M
Investing Cash Flow	-$58.00K	-$44.00K	-$1.98M	$2.31M
Financing Cash Flow	$4.33M	$4.61M	$9.06M	$5.61M
Share Repurchases	-$88.55M	$0.00	-$200.00K	—
Net Change in Cash	-$428.00K	-$224.00K	$125.00K	$413.00K

ONMD Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$137.00K	$155.00K	$177.00K	$891.00K	$96.00K	$292.00K
Cost of Revenue	$361.00K	$396.00K	$399.00K	$726.00K	$476.00K	$857.00K
Gross Profit	-$224.00K	-$241.00K	-$222.00K	$165.00K	-$380.00K	-$565.00K
Research & Development	$348.00K	$382.00K	$323.00K	$443.00K	$311.00K	$324.00K
Selling, General & Admin	$1.65M	$1.44M	$1.69M	$2.80M	$1.86M	$1.37M
Operating Expenses	$2.00M	$1.82M	$2.01M	$3.25M	$2.17M	$1.70M
Operating Income	-$2.22M	-$2.06M	-$2.23M	-$3.08M	-$2.55M	-$2.26M
EBITDA	-$1.86M	$3.04M	-$725.00K	-$3.12M	-$2.43M	-$2.16M
Pretax Income	-$1.90M	$2.98M	-$741.00K	-$3.14M	-$2.45M	-$2.17M
Net Income	-$1.90M	$2.98M	-$741.00K	-$3.14M	-$2.45M	-$2.17M
Diluted EPS	-0.06	0.07	-0.01	—	-0.04	-0.04
Diluted Shares	34.10M	38.41M	52.62M	—	55.32M	58.02M

ONMD Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$144.00K	$122.00K	$149.00K	$585.00K	$233.00K	$358.00K
Receivables	$247.00K	$254.00K	$582.00K	$495.00K	$697.00K	$664.00K
Current Assets	$1.63M	$2.27M	$1.45M	$2.10M	$1.46M	$1.31M
Total Assets	$1.73M	$2.34M	$1.51M	$2.15M	$1.51M	$1.36M
Current Liabilities	$18.15M	$6.16M	$5.00M	$4.83M	$5.36M	$4.73M
Long-Term Debt	—	—	—	$220.00K	$176.00K	$132.00K
Total Debt	$7.52M	$400.00K	$388.00K	$570.00K	$837.00K	$701.00K
Total Liabilities	$18.28M	$6.18M	$5.45M	$5.12M	$5.59M	$4.88M
Retained Earnings	-$103.47M	-$100.49M	-$101.23M	-$104.37M	-$106.82M	-$109.00M
Shareholders' Equity	-$16.55M	-$3.84M	-$3.94M	-$2.96M	-$4.08M	-$3.52M
Working Capital	-$16.52M	-$3.89M	-$3.56M	-$2.73M	-$3.90M	-$3.41M
Net Debt	$7.38M	$278.00K	$239.00K	—	$604.00K	$343.00K

ONMD Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$1.85M	-$2.19M	-$1.75M	-$1.71M	-$1.54M	-$1.88M
Capital Expenditure	-$5.00K	-$3.00K	—	-$5.00K	-$2.00K	-$9.00K
Free Cash Flow	-$1.86M	-$2.19M	-$1.75M	-$1.72M	-$1.54M	-$1.88M
Depreciation & Amortisation	$12.00K	$34.00K	$10.00K	$9.00K	$11.00K	$5.00K
Stock-Based Compensation	$208.00K	$197.00K	$142.00K	$1.49M	$431.00K	$463.00K
Investing Cash Flow	$1.92M	-$670.00K	$1.11M	-$51.00K	$352.00K	$56.00K
Financing Cash Flow	-$94.00K	$2.84M	$666.00K	$2.20M	$838.00K	$1.94M
Net Change in Cash	-$28.00K	-$22.00K	$27.00K	$436.00K	-$352.00K	$125.00K

Market Snapshot

About

OneMedNet Corp. operates a medical imaging data exchange platform connecting healthcare providers, clinical trial sites, and medical researchers. The platform enables secure sharing and analysis of medical images.